Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

AstraZeneca
Merck
Harvard Business School
Moodys
Mallinckrodt
Boehringer Ingelheim

Last Updated: June 29, 2022

CLINICAL TRIALS PROFILE FOR LUCEMYRA


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Lucemyra

Trial ID Title Status Sponsor Phase Start Date Summary
NCT03718065 ↗ Impact of Lofexidine on Stress, Craving and Opioid Use Recruiting National Institute on Drug Abuse (NIDA) Phase 2 2019-06-26 Individuals with opioid use disorder who are stabilized on buprenorphine or methadone will be randomly assigned to receive placebo or lofexidine for 5 weeks. At the end of five weeks, they will complete a human laboratory stress task and scripted opioid imagery task. Throughout the study a CREMA app (Cue Reactivity Ecological Momentary Assessment) will be used to monitor stress, craving and use in the natural environment.
NCT03718065 ↗ Impact of Lofexidine on Stress, Craving and Opioid Use Recruiting National Institutes of Health (NIH) Phase 2 2019-06-26 Individuals with opioid use disorder who are stabilized on buprenorphine or methadone will be randomly assigned to receive placebo or lofexidine for 5 weeks. At the end of five weeks, they will complete a human laboratory stress task and scripted opioid imagery task. Throughout the study a CREMA app (Cue Reactivity Ecological Momentary Assessment) will be used to monitor stress, craving and use in the natural environment.
NCT03718065 ↗ Impact of Lofexidine on Stress, Craving and Opioid Use Recruiting Medical University of South Carolina Phase 2 2019-06-26 Individuals with opioid use disorder who are stabilized on buprenorphine or methadone will be randomly assigned to receive placebo or lofexidine for 5 weeks. At the end of five weeks, they will complete a human laboratory stress task and scripted opioid imagery task. Throughout the study a CREMA app (Cue Reactivity Ecological Momentary Assessment) will be used to monitor stress, craving and use in the natural environment.
NCT04056182 ↗ Lofexidine for Management of Opioid Withdrawal With XR-NTX Treatment Completed US WorldMeds LLC Phase 2 2019-09-01 This is an open-label pilot trial to evaluate the safety and tolerability of lofexidine in the management of opioid withdrawal symptoms while initiating outpatient treatment with naltrexone. The initiation procedure will be a flexible detoxification lasting 2 to 10 days concluding with the injection of XR-Naltrexone (Vivitrol). Vivitrol is a long-acting injection that contains enough medicine to last for one month blocking the effects of opioids.
NCT04056182 ↗ Lofexidine for Management of Opioid Withdrawal With XR-NTX Treatment Completed Frances R Levin Phase 2 2019-09-01 This is an open-label pilot trial to evaluate the safety and tolerability of lofexidine in the management of opioid withdrawal symptoms while initiating outpatient treatment with naltrexone. The initiation procedure will be a flexible detoxification lasting 2 to 10 days concluding with the injection of XR-Naltrexone (Vivitrol). Vivitrol is a long-acting injection that contains enough medicine to last for one month blocking the effects of opioids.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Lucemyra

Condition Name

Condition Name for Lucemyra
Intervention Trials
Opioid-use Disorder 3
Opioid Withdrawal 2
Opiate Dependence 1
Opioid Addiction 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Lucemyra
Intervention Trials
Opioid-Related Disorders 4
Substance Withdrawal Syndrome 2
Stress Disorders, Traumatic 1
Stress Disorders, Post-Traumatic 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Lucemyra

Trials by Country

Trials by Country for Lucemyra
Location Trials
United States 18
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Lucemyra
Location Trials
New York 3
Maryland 2
Florida 1
California 1
South Carolina 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Lucemyra

Clinical Trial Phase

Clinical Trial Phase for Lucemyra
Clinical Trial Phase Trials
Phase 2/Phase 3 1
Phase 2 5
Phase 1 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Lucemyra
Clinical Trial Phase Trials
Recruiting 4
Completed 2
Suspended 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Lucemyra

Sponsor Name

Sponsor Name for Lucemyra
Sponsor Trials
US WorldMeds LLC 4
National Institute on Drug Abuse (NIDA) 3
United States Department of Defense 1
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Lucemyra
Sponsor Trials
Other 6
NIH 4
Industry 4
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Medtronic
Colorcon
Merck
Harvard Business School
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.